<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/855ACD43-8240-48FB-AF40-C8F87B294B74"><gtr:id>855ACD43-8240-48FB-AF40-C8F87B294B74</gtr:id><gtr:firstName>Nigel</gtr:firstName><gtr:otherNames>Shaun</gtr:otherNames><gtr:surname>Scrutton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CB830C05-3520-4333-A51E-7016BB4FE4A4"><gtr:id>CB830C05-3520-4333-A51E-7016BB4FE4A4</gtr:id><gtr:firstName>Eriko</gtr:firstName><gtr:surname>Takano</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FL027593%2F1"><gtr:id>ED2190EF-7B6D-42C9-967C-2260414FE8AA</gtr:id><gtr:title>13 ERA IB TERPENOSOME: Engineered compartments for monoterpenoid production using synthetic biology</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L027593/1</gtr:grantReference><gtr:abstractText>N/A</gtr:abstractText><gtr:technicalSummary>Terpenoids are commercially valuable natural fine chemicals with a variety of uses as drugs (taxol, artemisinin), nutraceuticals (carotenoids), cosmetics (astaxanthin), and agriculturals (gibberellins). Monoterpenoids are mainly produced in plants and are used as flavours (e.g. limonene), and fragrances (e.g. carveol), as well as precursors for pharmaceutical molecules. However, the natural production of commercially relevant monoterpenes is limited, since their extraction from plants is costly and inefficient, and the alternative chemical synthesis involves long and complex, multi-step protocols. Monoterpenes produced from bacteria using heterologous biosynthesis pathways would be ideal for sustainability and compound diversity; however, so far it has produced low yields, while sesquiterpenes have been successfully overproduced by, e.g., Martin and coworkers (2003, Nature Biotech 21:796-802). TERPENOSOME will develop yeast and bacterial monoterpenoid producing strains using synthetic biology approaches, which bypass many of the production constraints associated with chemical synthesis and isolation from natural resources.

Metabolosomes are recently discovered bacterial organelles, which are large structures composed of an exterior protein shell with multiple enzymes compartmentalised on the inside. There are currently only two examples reported in the literature for the localisation of green fluorescent protein inside ethanolamine utilization metabolosomes (Choudhary et al., 2012). These serve as excellent proof-of-concept examples to show: (1) that non-native proteins can be targeted inside metabolosomes, and (2) that metabolosomes can be used as closed scaffolds inside host organisms. 

TERPENOSOME will be the first to apply the metabolosome to synthetically designed monoterpene biosynthesis for production improvement, side product reduction through improved metabolic control and higher local flux, and to avoid toxicity limiting production levels.</gtr:technicalSummary><gtr:potentialImpactText>N/A</gtr:potentialImpactText><gtr:fund><gtr:end>2018-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>697623</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cold Spring Harbour Laboratory course in Synthetic Biology</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Society for General Microbiology (SGM)</gtr:fundingOrg><gtr:id>C86F2E4B-75C3-4A65-B9DC-B7C03ADE5377</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The project is still has about an year to go and the findings has not been used yet.</gtr:description><gtr:id>7F4D92A2-D9C3-4D5E-8F32-0E3DE5B11628</gtr:id><gtr:impactTypes/></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The engineered bacteria with the monoterpenoid biosynthesis pathways are producing limonene, geraniol and linalool which are all monoterpenoids and are the source of smells for lemon, rose and lavendar.</gtr:description><gtr:exploitationPathways>The end compounds generated may have use to industry who requires new or modified monoterpenes for fragrances. The technology developed can also be taken forward by the same industries but also other academics and industry who have interest in generating chemical diversity using synthetic biology approaches.</gtr:exploitationPathways><gtr:id>CD998493-B45A-42B8-97D3-CCC18BFEF571</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Chemicals,Energy,Environment,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.mib.ac.uk/research/portfolio/terpenosome/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>External advisor for European Commission Scientific Committee on Emerging and Newly Identified Health Risks on synthetic biology</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>D669F0A6-899A-4F53-A57C-A1C6DA08E96A</gtr:id><gtr:impact>Made huge impact on the policy for defining Synthetic Biology, identifying the risks for Synthetic Biology and future recommendations in Synthetic Biology risk assessment at a European level.</gtr:impact><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Bacteria, fungi and plants produce an enormous variety of small functional molecules with manifold biological activities, e.g., as antibiotics, immunosuppressants, and signaling molecules. The biosynthesis of such molecules is encoded by compact genomic units (biosynthetic gene clusters). Over the past decades, hundreds of biosynthetic gene clusters encoding the biosynthesis of secondary metabolites have been characterized. Although dozens of biosynthetic gene clusters are published and thousands are sequenced annually (with or without their surrounding genome sequence), very little effort has been put into structuring this information. Hence, it is currently very difficult to prioritize gene clusters for experimental characterization, to identify the fundamental architectural principles of biosynthetic gene clusters, to understand which ecological parameters drive their evolution, and to obtain an informative 'parts registry' of building blocks for the synthetic biology of secondary metabolite biosynthesis.
Therefore, developing a genomic standard for experimentally characterized biosynthetic gene clusters (e.g., Minimum Information about a BIosynthetic Gene cluster, MIBiG) would be of great value to the field of microbial secondary metabolism. Building on the MIxS standards for ecological and environmental contextualization, information on, e.g., enzyme function, substrate specificities, functional subclusters, regulatory and transport systems, operon structure, chemical moieties of the end compound and its intermediates, biosynthetic precursor compounds, compound bioactivity and molecular targets and compound toxicity could be added to allow cross-linking the information to biochemistry, pharmaceutical properties, genomic structure and ecology. Using the already developed computational pipeline for analysis of biosynthetic gene clusters antiSMASH (http://antismash.secondarymetabolites.org/), which has quickly become a standard in the field, information on characterized biosynthetic gene clusters will be linked to the untapped wealth of thousands of unknown gene clusters that have recently been unearthed by massive genome sequencing efforts. Taken together, this has the potential to guide the characterization of new metabolites by allowing to optimize the sampling of diversity at different levels and to identify the biochemical, genomic and ecological parameters that are key predictors of pharmaceutically relevant biological activities. Moreover, it can transform the unordered pile of literature on secondary metabolites into a structured and annotated catalogue of parts that can be used as building blocks to design new biochemical pathways with synthetic biology.</gtr:description><gtr:id>48CC8641-CE2D-4133-BA59-DE17D8994FBD</gtr:id><gtr:impact>MIBiG will the better description and contextualization of sequence data, of important sequence elements, with concrete biotechnological applications that will increase the visibility and applicability of the GSC and its mission in the fields of applied microbiology, synthetic biology, natural products chemistry and enzymology.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MIBiG</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://gensc.org/projects/mibig/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57D3EF54-A623-473C-8E0C-D059E4120CDD"><gtr:id>57D3EF54-A623-473C-8E0C-D059E4120CDD</gtr:id><gtr:title>Bacterial Microcompartments: Biomaterials for Synthetic Biology-Based Compartmentalization Strategies</gtr:title><gtr:parentPublicationTitle>ACS Biomaterials Science &amp; Engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/29909c4dbf165dc9b721631c5f1f113c"><gtr:id>29909c4dbf165dc9b721631c5f1f113c</gtr:id><gtr:otherNames>Chessher A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AB244BD8-7262-42C9-A74A-04126452951F"><gtr:id>AB244BD8-7262-42C9-A74A-04126452951F</gtr:id><gtr:title>A 'Plug and Play' Platform for the Production of Diverse Monoterpene Hydrocarbon Scaffolds inEscherichia coli.</gtr:title><gtr:parentPublicationTitle>ChemistrySelect</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf49b6b6b87f88d4700e8b28342b5626"><gtr:id>bf49b6b6b87f88d4700e8b28342b5626</gtr:id><gtr:otherNames>Leferink N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70FD258A-69E7-468C-9B70-CB3A824DFEA4"><gtr:id>70FD258A-69E7-468C-9B70-CB3A824DFEA4</gtr:id><gtr:title>Towards synthesis of monoterpenes and derivatives using synthetic biology.</gtr:title><gtr:parentPublicationTitle>Current opinion in chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d8ffd55d719b410c5bd8e877a6dd9c3"><gtr:id>4d8ffd55d719b410c5bd8e877a6dd9c3</gtr:id><gtr:otherNames>Zebec Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1367-5931</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06C7AC9A-FFDD-4A98-9F00-029076961083"><gtr:id>06C7AC9A-FFDD-4A98-9F00-029076961083</gtr:id><gtr:title>Enzymatic Menthol Production: One-Pot Approach Using Engineered Escherichia coli.</gtr:title><gtr:parentPublicationTitle>ACS synthetic biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/945abe6e38e453d4e73469f599c3a072"><gtr:id>945abe6e38e453d4e73469f599c3a072</gtr:id><gtr:otherNames>Toogood HS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2161-5063</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90EC1501-1680-4DB2-B68B-A760967DF94D"><gtr:id>90EC1501-1680-4DB2-B68B-A760967DF94D</gtr:id><gtr:title>Synthetic Biology of Natural Products.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be38063b5d41a616f3c54907ec097208"><gtr:id>be38063b5d41a616f3c54907ec097208</gtr:id><gtr:otherNames>Breitling R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1943-0264</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47D7D175-5F2B-491E-AA58-974AE4E612A2"><gtr:id>47D7D175-5F2B-491E-AA58-974AE4E612A2</gtr:id><gtr:title>SYNBIOCHEM-a SynBio foundry for the biosynthesis and sustainable production of fine and speciality chemicals.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/706f3fca80d0946ee33cf82e22864d70"><gtr:id>706f3fca80d0946ee33cf82e22864d70</gtr:id><gtr:otherNames>Carbonell P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L027593/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>17F21DBC-4946-4262-AD07-9914F6EA12F7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioengineering</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>B971A4E6-FF4B-45BC-96D6-1E289961490D</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Catalysis &amp; enzymology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>19C5179C-0522-47E8-82DA-48583B56264E</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Metabolic engineering</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>